A) Overall survival and (B) event-free survival for the subgroup of... | Download Scientific Diagram
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology
Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation - ScienceDirect
Kaplan–Meyer estimate of overall survival (OS) and event-free survival... | Download Scientific Diagram
Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia - ScienceDirect
A) Overall survival (OS) and (B) eventfree survival (EFS) for patients... | Download Scientific Diagram
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia | Haematologica
Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
View Image
Event-free survival (EFS) of patients with acute promylocytic leukemia... | Download Scientific Diagram
Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 | Leukemia
Overall survival (a) and event-free survival (b) of adult acute... | Download High-Resolution Scientific Diagram
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia | Leukemia
Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy | PLOS ONE
Interpretation of clinical endpoints in trials of acute myeloid leukemia - ScienceDirect
Event-free survival, cumulative incidence of relapse and overall... | Download Scientific Diagram
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor - Clinical Lymphoma, Myeloma and Leukemia
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica